Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody
Clinical trial NCT04563923 · COMPLETED
Trial details
- NCT number
- NCT04563923
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-10
- Primary completion
- 2023-04-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.